MOUNTAIN VIEW, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure ® procedure, the most effective non-surgical permanent birth control method available*, ...

Essure began as an exciting new contraceptive option for women, but when adverse event reports began piling up, it became a focus of controversy and litigation. It has now been removed from the market ...

Safety reports related to Bayer's Essure birth control device have been piling up at the FDA and now, the agency is making its move. It issued an order restricting the sale and distribution of Essure ...

WASHINGTON — The Food and Drug Administration said Monday that it is restricting the sale and distribution of Essure, a controversial contraceptive device that some patient advocates want taken off ...

NEW YORK (Reuters) - Life sciences company Bayer AG said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable ...

WHIPPANY, N.J., July 26, 2018 /PRNewswire/ -- Bayer is reminding women with Essure that the safety profile of Essure, the only Food and Drug Administration (FDA)-approved non-incisional form of ...

Bayer is continuing the war of words against “The Bleeding Edge,” Netflix‘s documentary about harms inflicted by the massive medical-device industry. The Netflix film includes an examination of ...

The Essure contraceptive was marketed as a way to give women highly reliable birth control and millions of women trusted the product to give them peace of mind. When the product failed, leading to ...

LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer announced today that it has reached agreements with plaintiff law firms to resolve approximately 90% of the nearly 39,000 total filed and unfiled U.S.